UnitedHealth Group Incorporated (UNH) FY2026 Q1 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-03-31

Swipe to see the full flow
UnitedHealth Group Incorporated cash flow reconciliation, Jan 1, 2026 through Mar 31, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net earnings → Net cash from operating activities: $6,481,000,000.00Other assets → Operating adjustments reconciliation: $2,919,000,000.00Accounts payable and other liabilities → Operating adjustments reconciliation: $1,055,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $1,029,000,000.00Deferred income taxes → Operating adjustments reconciliation: $540,000,000.00Share-based compensation → Operating adjustments reconciliation: $348,000,000.00Medical costs payable → Operating adjustments reconciliation: $296,000,000.00Loss on sale of subsidiary and subsidiaries held for sale → Operating adjustments reconciliation: $72,000,000.00Unearned revenues → Operating adjustments reconciliation: $20,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $2,431,000,000.00Operating adjustments reconciliation → Accounts receivable: $3,544,000,000.00Operating adjustments reconciliation → Other, net: $304,000,000.00Maturities of investments → investing reconciliation: $2,285,000,000.00Sales of investments → investing reconciliation: $1,878,000,000.00Cash received from dispositions and other strategic transactions, net → investing reconciliation: $1,081,000,000.00Repayments and maturities of loans → investing reconciliation: $699,000,000.00Repayments of care provider loans - cyberattack → investing reconciliation: $82,000,000.00Other, net → investing reconciliation: $21,000,000.00investing reconciliation → Purchases of investments: $6,515,000,000.00investing reconciliation → Originations And Purchases Of Loans: $1,215,000,000.00investing reconciliation → Purchases of property, equipment and capitalized software: $763,000,000.00Net cash used in financing activities → financing reconciliation: $2,992,000,000.00Proceeds from short-term borrowings, net → financing reconciliation: $1,100,000,000.00Customer funds administered → financing reconciliation: $600,000,000.00Proceeds from common stock issuances → financing reconciliation: $231,000,000.00financing reconciliation → Cash dividends paid: $2,005,000,000.00financing reconciliation → Repayments of long-term debt: $1,500,000,000.00financing reconciliation → Other, net: $1,418,000,000.00Net cash used in investing activities → investing reconciliation: $2,447,000,000.00Other changes in cash (calculated) → Cash sources and uses: $163,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $24,365,000,000.00Net cash from operating activities → Cash sources and uses: $8,912,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $28,001,000,000.00Cash sources and uses → Net cash used in investing activities: $2,447,000,000.00Cash sources and uses → Net cash used in financing activities: $2,992,000,000.00Net earnings: $6,481,000,000.00Net earnings+$6.48 BDepreciation and amortization: $1,029,000,000.00Depreciation & amortization+$1.03 BDeferred income taxes: $540,000,000.00Deferred income taxes+$540.00 MShare-based compensation: $348,000,000.00Stock-based compensation+$348.00 MLoss on sale of subsidiary and subsidiaries held for sale: $72,000,000.00Subsidiary sale gain & loss+$72.00 MOther, net: -$304,000,000.00Other non-cash items−$304.00 MAccounts receivable: -$3,544,000,000.00Accounts receivable−$3.54 BOther assets: $2,919,000,000.00Other operating assets+$2.92 BMedical costs payable: $296,000,000.00Health insurance liabilities+$296.00 MAccounts payable and other liabilities: $1,055,000,000.00Payables & accrued liabilities+$1.06 BUnearned revenues: $20,000,000.00Unearned revenue+$20.00 MNet cash from operating activities: $8,912,000,000.00Operating cash+$8.91 BOperating adjustments reconciliation: $6,279,000,000.00Common share repurchases: $0.00Cash dividends paid: -$2,005,000,000.00Common dividends paid−$2.01 BProceeds from common stock issuances: $231,000,000.00Common stock issued+$231.00 MRepayments of long-term debt: -$1,500,000,000.00Long-term debt repaid−$1.50 BProceeds from short-term borrowings, net: $1,100,000,000.00Commercial paper, net+$1.10 BCustomer funds administered: $600,000,000.00Deposits, net+$600.00 MOther, net: -$1,418,000,000.00Other financing, net−$1.42 BNet cash used in financing activities: -$2,992,000,000.00. Cash required to fund net payments.Financing cash−$2.99 Bfinancing reconciliation: $4,923,000,000.00Purchases of investments: -$6,515,000,000.00Investment purchases−$6.52 BSales of investments: $1,878,000,000.00AFS securities sales+$1.88 BMaturities of investments: $2,285,000,000.00AFS securities maturities+$2.29 BCash paid for acquisitions and other transactions, net of cash assumed: $0.00Purchases of property, equipment and capitalized software: -$763,000,000.00PP&E purchases−$763.00 MRepayments of care provider loans - cyberattack: $82,000,000.00Cyberattack care loans repaid+$82.00 MOriginations And Purchases Of Loans: -$1,215,000,000.00Loan originations & purchases−$1.22 BRepayments and maturities of loans: $699,000,000.00Loan repayments & maturities+$699.00 MCash received from dispositions and other strategic transactions, net: $1,081,000,000.00Business sales+$1.08 BOther, net: $21,000,000.00Other investing, net+$21.00 MNet cash used in investing activities: -$2,447,000,000.00. Cash required to fund net payments.Investing cash−$2.45 Binvesting reconciliation: $8,493,000,000.00Cash sources and uses: $33,440,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $24,365,000,000.00Beginning cash$24.37 BEnding cash: Cash, cash equivalents, and restricted cash: $28,001,000,000.00Ending cash$28.00 BOther changes in cash (calculated): $163,000,000.00Other changes in cash(calculated)+$163.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$8.15 BOperating cash − cash spent on PP&ECash flow / Net income1.38×Operating cash flow ÷ net incomeNet cash change+$3.64 BEnding cash − beginning cash
Chart details

UnitedHealth Group Incorporated cash flow reconciliation, Jan 1, 2026 through Mar 31, 2026

Cash flows for Jan 1, 2026 through Mar 31, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Mar 31, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
24,365,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
8,912,000,000 US dollars. Net cash provided.
Net earnings
6,481,000,000 US dollars
Depreciation and amortization
1,029,000,000 US dollars
Deferred income taxes
540,000,000 US dollars
Share-based compensation
348,000,000 US dollars
Loss on sale of subsidiary and subsidiaries held for sale
72,000,000 US dollars
Other, net
negative 304,000,000 US dollars
Accounts receivable
negative 3,544,000,000 US dollars
Other assets
2,919,000,000 US dollars
Medical costs payable
296,000,000 US dollars
Accounts payable and other liabilities
1,055,000,000 US dollars
Unearned revenues
20,000,000 US dollars
Investing activities
negative 2,447,000,000 US dollars. Net cash used.
Purchases of investments
negative 6,515,000,000 US dollars
Sales of investments
1,878,000,000 US dollars
Maturities of investments
2,285,000,000 US dollars
Cash paid for acquisitions and other transactions, net of cash assumed
0 US dollars
Purchases of property, equipment and capitalized software
negative 763,000,000 US dollars
Repayments of care provider loans - cyberattack
82,000,000 US dollars
Originations And Purchases Of Loans
negative 1,215,000,000 US dollars
Repayments and maturities of loans
699,000,000 US dollars
Cash received from dispositions and other strategic transactions, net
1,081,000,000 US dollars
Other, net
21,000,000 US dollars
Financing activities
negative 2,992,000,000 US dollars. Net cash used.
Common share repurchases
0 US dollars
Cash dividends paid
negative 2,005,000,000 US dollars
Proceeds from common stock issuances
231,000,000 US dollars
Repayments of long-term debt
negative 1,500,000,000 US dollars
Proceeds from short-term borrowings, net
1,100,000,000 US dollars
Customer funds administered
600,000,000 US dollars
Other, net
negative 1,418,000,000 US dollars
Operating adjustment reconciliation
6,279,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
4,923,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
8,493,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Other changes in cash (calculated)
163,000,000 US dollars. Into cash; drawn as the small gray flow above beginning cash.
Ending cash on Mar 31, 2026
28,001,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
33,440,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
3,636,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.38×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
8,912,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
763,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
8,149,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $2.43B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 8,912,000,000 US dollars minus 763,000,000 US dollars equals 8,149,000,000 US dollars.
UnitedHealth Group Incorporated (UNH) FY2026 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!